Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Contents: Preface. Acknowledgments. Part One: Early Days. Part Two: Heyday. Part Three: Themes. Part Four: Legislation. Part Five: Epilogue. Index.Originally published in 1961.The Princeton Legacy Library uses the latest print-on-demand technology to again make available previously out-of-print books from the distinguished backlist of Princeton University Press. These editions preserve the original texts of these important books while presenting them in durable paperback and hardcover editions. The goal of the Princeton Legacy Library is to vastly increase access to the rich scholarly heritage found in the thousands of books published by Princeton University Press since its founding in 1905.

Patent medicines --- Patent medicines. --- Medicines, Patent, proprietary, etc. --- Proprietary drugs --- Proprietary medicines --- Drugs --- Drugs, Nonprescription --- Law and legislation --- Medicine shows --- History. --- Peddling --- Quacks and quackery

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Industrial and intellectual property --- 347.771 <4> --- Patent laws and legislation --- -Patent laws and legislation --- -Patent medicines --- -Medicines, Patent, proprietary, etc. --- Proprietary drugs --- Proprietary medicines --- Drugs --- Drugs, Nonprescription --- Law, Patent --- Patents --- Scientific property --- Industrial laws and legislation --- Industrial property --- Trade regulation --- Copyright --- Octrooirecht. Brevet. Know-how--Europa --- Law and legislation --- -Law and legislation --- Patent medicines --- -Octrooirecht. Brevet. Know-how--Europa --- -347.771 <4> --- 347.771 <4> Octrooirecht. Brevet. Know-how--Europa --- Medicines, Patent, proprietary, etc.

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

In this book, the ownership, distribution and sale of patent medicines across Georgian England are explored for the first time, transforming our understanding of healthcare provision and the use of the printed word in that era. Patent medicines constituted a national industry which was largely popular, reputable and stable, not the visible manifestation of dishonest quackery as described later by doctors and many historians. Much of the distribution, promotion and sale of patent medicines was centrally controlled with directed advertising, specialisation, fixed prices and national procedures, and for the first time we can see the detailed working of a national market for a class of Georgian consumer goods. Furthermore, contemporaries were aware that changes in the consumers’ ‘imagination’ increased the benefits of patent medicines above the effects of their pharmaceutical components. As the imagination was altered by the printed word, print can be considered as an essential ingredient of patent medicines. This book will challenge the assumptions of all those interested in the medical, business or print history of the period.

Patent medicines --- History. --- History --- Medicines, Patent, proprietary, etc. --- Proprietary drugs --- Proprietary medicines --- Drugs --- Drugs, Nonprescription --- Medicine. --- Great Britain-History. --- Law-History. --- History of Science. --- History of Medicine. --- History of Britain and Ireland. --- Legal History. --- Clinical sciences --- Medical profession --- Human biology --- Life sciences --- Medical sciences --- Pathology --- Physicians --- Annals --- Auxiliary sciences of history --- Health Workforce --- Medicine—History. --- Great Britain—History. --- Law—History.

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

This book investigates lifecycle management strategies used by pharmaceutical companies attempting to maximize the value of their product portfolio. Such strategies are sometimes referred to by generic drug companies as “evergreening”. The analysis focuses on two of these strategies, namely product improvements and product line extensions. In particular, an evaluation of the patents that follow the basic one and that accompany the development of a drug from research to market is attempted. Two “blockbuster” drugs, Taxotere and Xalatan, were randomly chosen to carry out such analysis. The patent portfolio of the originator companies is outlined and some important patents for each area of research (e.g. formulations, combinations, delivery devices) are shortly described. Patent filing trends for the two drugs, both in regards of the originator and in regards of other competing companies (amongst these also the generics) are schematically shown.

Patent medicines --- Drugs --- Law and legislation --- Economic aspects --- Medicines, Patent, proprietary, etc. --- Proprietary drugs --- Proprietary medicines --- Drugs, Nonprescription --- Medicaments --- Medications --- Medicine (Drugs) --- Medicines (Drugs) --- Pharmaceuticals --- Prescription drugs --- Bioactive compounds --- Medical supplies --- Pharmacopoeias --- Chemotherapy --- Materia medica --- Pharmacology --- Pharmacy --- Markenrecht --- Urheberrecht / Gewerblicher Rechtsschutz und Medienrecht --- Gewerblicher Rechtsschutz

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Across the world, developing countries are attempting to balance the international standards of intellectual property concerning pharmaceutical patents against the urgent need for accessible and affordable medicines. In this timely and necessary book, Monirul Azam examines the attempts of several developing countries to walk this fine line.

Patent medicines --- Drug accessibility --- Pharmaceutical industry --- Pharmaceutical policy. --- Intellectual property --- Intellectual property (International law) --- Law and legislation --- Cost control. --- International law --- Drug policy --- Drugs --- Drugs and state --- Pharmacy --- Pharmacy and state --- State and drugs --- State and pharmacy --- Medical policy --- Drug industry --- Drug trade --- Medicine industry --- Medicines industry --- Prescription medicine industry --- Chemical industry --- Access to drugs --- Accessibility of drugs --- Availability of drugs --- Drug availability --- Medicines, Patent, proprietary, etc. --- Proprietary drugs --- Proprietary medicines --- Drugs, Nonprescription --- Government policy